Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EDAP's MRI (magnetic resonance imaging)-guided HIFU (high intensity focused ultrasound) used for breast cancer:

This article was originally published in Clinica

Executive Summary

French company EDAP TMS has reported that its MRI-guided ultrasound treatment has been used to treat breast cancer for the first time in Europe. Doctors in Germany used the company's MRI-guided high intensity focused ultrasound (HIFU) system to treat the first participant of an 18-patient trial of the product. The system allows doctors to deliver HIFU to a focal point where malignant cells are heated and destroyed. The procedure lasts around three hours, including 80 minutes for the treatment itself. Vaulx-en-Velin-based EDAP already markets its HIFU-based treatment for prostate cancer, Ablatherm, in Europe

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069488

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel